Krish Bhadra, MD, named, nominated to board of two national organizations

Krish Bhadra, M.D., interventional pulmonologist at CHI Memorial’s Buz Standefer Lung Center, has been named and nominated to leadership roles at two national organizations.  He is the only private practice physician named to the Scientific Leadership Board of the GO2 Lung Cancer Foundation, which recently formed when the Bonnie J. Addario Lung Cancer Foundation (ALCF) and Lung Cancer Alliance (LCA) joined together. Dr. Bhadra has also been nominated for the American Association of Bronchology and Interventional Pulmonology Board of Trustees, election pending.

As a fellowship-trained physician with the Buz Standefer Lung Center, Dr. Bhadra is the first in the world to use FluoroNavigational bronchoscopy, and CHI Memorialis one of few sites in the world to use Cone Beam CT (CBCT). These are advanced technologies that detect lung cancer in its early stages when lung cancer is most treatable and survival rates increase significantly.

Dr. Bhadra received his medical degree from the University of Miami Miller School of Medicine in Miami, FL.  He completed his internship, residency, and a fellowship in pulmonary and critical care medicine at the University of Vermont College of Medicine in Burlington.  He completed a fellowship in interventional pulmonology at the University of Pennsylvania in Philadelphia.  He is board-certified in critical care, pulmonary disease, and interventional pulmonology.